Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Field Trip Health Ltd.
  6. Summary
    FTRP   CA31656R1029

FIELD TRIP HEALTH LTD.

(FTRP)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Toronto Stock Exchange
09/20/2021 09/21/2021 09/22/2021 09/23/2021 09/24/2021 Date
5.42(c) 5.7(c) 5.96(c) 6.27(c) 5.88(c) Last
34 779 32 070 39 273 48 629 54 468 Volume
-1.09% +5.17% +4.56% +5.20% -6.22% Change
More quotes
Estimated financial data (e)
Sales 2022 7,66 M 6,05 M 6,05 M
Net income 2022 -49,7 M -39,2 M -39,2 M
Net Debt 2022 - - -
P/E ratio 2022 -7,14x
Yield 2022 -
Sales 2023 28,7 M 22,7 M 22,7 M
Net income 2023 -58,4 M -46,1 M -46,1 M
Net Debt 2023 - - -
P/E ratio 2023 -6,32x
Yield 2023 -
Capitalization 339 M 267 M 268 M
Capi. / Sales 2022 44,3x
Capi. / Sales 2023 11,8x
Nbr of Employees 104
Free-Float 76,9%
More Financials
Company
Field Trip Health Ltd., formerly Newton Energy Corporation, is engaged in the development and delivery of psychedelic therapies. Through its Field Trip Discovery, the Company develops psychedelic molecules and conducts research on plant-based psychedelics. Field Trip Discovery focuses on developing medicines targeting the serotonin 5HT2A serotonin receptor. It is also focused on developing Field Trip Health hubs for... 
Sector
Biotechnology & Medical Research
Calendar
09/29 | 09:20amPresentation
More about the company
Ratings of Field Trip Health Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about FIELD TRIP HEALTH LTD.
09/20FIELD TRIP HEALTH LTD.(TSX : FTRP) added to S&P Global BMI Index
CI
09/09FIELD TRIP HEALTH : To Pursue Treatment Resistant Depression and Postpartum Depression as ..
MT
09/09FIELD TRIP HEALTH BRIEF : Says To Pursue Treatment Resistant Depression and Postpartum Dep..
MT
09/09Field Trip Health Ltd. to Pursue Treatment Resistant Depression and Postpartum Depressi..
GL
09/09Field Trip Health Ltd. Announces Anita H. Clayton, MD, Has Joined Its Scientific Adviso..
CI
09/09Field Trip Health Ltd. to Pursue Treatment Resistant Depression and Postpartum Depressi..
CI
09/07Field Trip Health Opens First Psychedelic Therapy Healthcare Facility
CI
09/02Field Trip Health Ltd. Announces Launch of KAP Co-Op Program
CI
09/01FIELD TRIP HEALTH : Toronto Stock Exchange, Field Trip Health Ltd., C-Suite at The Open
AQ
09/01Wall Street Set for Narrow Gains, ADP Payrolls Miss Estimates
MT
09/01FIELD TRIP HEALTH : HC Wainwright Starts Field Trip Health at Buy with $20 Price Target
MT
09/01Top Premarket Gainers
MT
08/31FIELD TRIP HEALTH : Launches Paid Partnership Program for Independent Psychedelic Therapis..
MT
08/31FIELD TRIP HEALTH LTD. : Announces Launch Of “Kap Co-Operative” Program, Enabl..
AQ
08/16MT NEWSWIRES CANADA OVERNIGHT STOCKS : Field Trip Health; PyroGenesis
MT
More news
News in other languages on FIELD TRIP HEALTH LTD.
09/23DELIC HOLDINGS CORP. : Meet Delic kündigt vollständiges Veranstaltungs-, Vortrags- und Ent..
More news
Analyst Recommendations on FIELD TRIP HEALTH LTD.
More recommendations
Chart FIELD TRIP HEALTH LTD.
Duration : Period :
Field Trip Health Ltd. Technical Analysis Chart | FTRP | CA31656R1029 | MarketScreener
Technical analysis trends FIELD TRIP HEALTH LTD.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 5,88 CAD
Average target price 12,73 CAD
Spread / Average Target 117%
EPS Revisions
Managers and Directors
Joseph del Moral Chief Executive Officer & Director
Hannan Fleiman President & Director
Tyler Dyck Treasurer & Finance Director
Donna Wong Chief Financial Officer
Ronan Levy Executive Chairman
Sector and Competitors
1st jan.Capi. (M$)
FIELD TRIP HEALTH LTD.0.00%267
GILEAD SCIENCES, INC.22.19%89 259
BIONTECH SE309.08%80 542
REGENERON PHARMACEUTICALS32.25%66 425
WUXI APPTEC CO., LTD.34.39%59 817
VERTEX PHARMACEUTICALS-22.31%47 634